✦ LIBER ✦

Bleeding, mortality, and antiplatelet therapy: Results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial

✍ Scribed by Saurav Chatterjee; Subhankar Maitra; Anasua Chakraborty

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bleeding, mortality, and antiplatelet th

✍ Jeffrey S. Berger; Deepak L. Bhatt; P. Gabriel Steg; Steven R. Steinhubl; Gilles 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 327 KB

Reply to the letter by Chatterjee et al

✍ Jeffery S. Berger; Deepak L. Bhatt 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Bleeding Complications With Dual Antipla

✍ P.B. Berger; D.L. Bhatt; V. Fuster 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 67 KB

A global view of atherothrombosis: Basel

✍ Deepak L. Bhatt; Keith A. Fox; Werner Hacke; Peter B. Berger; Henry R. Black; Wi 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 114 KB

Ethnic variation in adverse cardiovascul

✍ Koon-Hou Mak; Deepak L. Bhatt; Mingyuan Shao; Graeme J. Hankey; J. Donald Easton 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 421 KB

Clopidogrel added to aspirin versus aspi

✍ Deepak L. Bhatt; Eric J. Topol 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 112 KB